Literature DB >> 9351377

Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke.

N Mero1, M Syvänne, B Eliasson, U Smith, M R Taskinen.   

Abstract

Smokers have an increased risk for coronary artery disease (CAD), which can only partly be explained by fasting lipoprotein changes. Recent studies have indicated that smokers express metabolic abnormalities characteristic of insulin resistance syndrome. A preliminary study reported an increased postprandial triglyceride (TG) response in smokers compared with nonsmokers. To investigate the effect of smoking on postprandial lipemia, a fat-rich mixed meal (837 kcal, 63 g of fat) was served to 12 healthy smokers and 12 controls with similar fasting lipoprotein profiles, body composition, and lifestyles. Blood was drawn before and 3, 4, 6, and 8 hours postprandially, and triglyceride-rich lipoprotein (TRL) fractions (chylomicrons, VLDL1, VLDL2, and IDL) were separated with density gradient ultracentrifugation. Pre- and postprandial TG, retinyl esters (RE), apolipoprotein B-48 (apoB-48) and B-100 (apoB-100) were measured in each fraction. Smokers showed a significantly increased postprandial TG response in chylomicrons, VLDL1, and VLDL2. The areas under the incremental curve (AUIC) of apoB-48 in chylomicrons (2.83 +/- 0.84 versus 0.56 +/- 0.17; P < .05) and VLDL1 (10.17 +/- 1.96 versus 2.95 +/- 2.44; P = < .01) were markedly higher in smokers than in controls. Changes of RE responses of all TRL fractions were consistent with those of apoB-48. Postprandial apoB-100 concentrations and lipolytic enzymes were similar between the two groups. In conclusion, smokers have the syndrome of impaired TG tolerance because of defective clearance of chylomicrons and their remnants. Prolonged residence time of atherogenic remnant particles may constitute a significant risk factor for CAD in smokers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351377     DOI: 10.1161/01.atv.17.10.2096

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

Authors:  N Matikainen; S Mänttäri; A Schweizer; A Ulvestad; D Mills; B E Dunning; J E Foley; M-R Taskinen
Journal:  Diabetologia       Date:  2006-07-01       Impact factor: 10.122

3.  Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

Authors:  B Eliasson; D Möller-Goede; K Eeg-Olofsson; C Wilson; J Cederholm; P Fleck; M Diamant; M-R Taskinen; U Smith
Journal:  Diabetologia       Date:  2012-01-12       Impact factor: 10.122

4.  Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors:  Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

5.  Enteral administration of high-fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial translocation.

Authors:  Misha D P Luyer; Jan A Jacobs; Anita C E Vreugdenhil; M'hamed Hadfoune; Cornelis H C Dejong; Wim A Buurman; Jan Willem M Greve
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

6.  Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.

Authors:  Patrick Couture; André J Tremblay; Isabelle Kelly; Valéry Lemelin; Arnaud Droit; Benoît Lamarche
Journal:  J Lipid Res       Date:  2013-10-18       Impact factor: 5.922

7.  Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases.

Authors:  Boudewijn Klop; Spencer D Proctor; John C Mamo; Kathleen M Botham; Manuel Castro Cabezas
Journal:  Int J Vasc Med       Date:  2011-09-25

Review 8.  Postprandial lipemia: factoring in lipemic response for ranking foods for their healthiness.

Authors:  Cintia Botelho Dias; Paul J Moughan; Lisa G Wood; Harjinder Singh; Manohar L Garg
Journal:  Lipids Health Dis       Date:  2017-09-18       Impact factor: 3.876

9.  Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD7687 on plasma triacylglycerol.

Authors:  Pablo Morentin Gutierrez; James Yates; Catarina Nilsson; Sue Birtles
Journal:  Pharmacol Res Perspect       Date:  2019-03-09

10.  Postprandial oxidative stress in exercise trained and sedentary cigarette smokers.

Authors:  Richard J Bloomer; Kelsey H Fisher-Wellman
Journal:  Int J Environ Res Public Health       Date:  2009-02-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.